zepbound is tirzepatide Zepbound® (Tirzepatide) Tirzepatide (Zepbound) Ohio: JourneyLite Prescription
Description
Completion of the trials main phase is expected in September 2025, and the 52-week extension (in which participants and investigators remain blinded to treatment assignment) will continue to October 2026

MORPHEUS8 What it does: Combines microneedling with radiofrequency for deep collagen remodeling

This post hoc analysis investigated the association between major adverse cardiovascular events (MACE) and baseline kidney parameters and whether the effect of semaglutide on MACE risk was impacted by baseline kidney parameters in people with T2D at high cardiovascular risk

Compounded tirzepatide remains legal and available through licensed pharmacies

Evidence shows some regain after stopping GLP-1s

HbA1c decreased by 1.0% at 6 months (P<0.001), with reductions of 1.0%, 1.2%, and 0.9% at 1, 3, and 12 months post-EDN, respectively
